Recombinant Human GDF-15 Protein, Active, Low Endotoxin
Beta LifeScience
SKU/CAT #: BEP-0010
Recombinant Human GDF-15 (2 ug/lane) on SDS-PAGE under reducing (R) and non-reducing (NR) conditions. The gel was stained using Coomassie® Blue showing single bands at 12 kDa and 24 kDa, respectively, and purity greater than 98%.
Recombinant Human GDF-15 Protein, Active, Low Endotoxin
Beta LifeScience
SKU/CAT #: BEP-0010
Regular price$1,23400
$1,234.00
/
Submit an inquiry or email sales for a custom bulk quote. Our products are highly customizable to meet your specific needs. You can choose options such as endotoxin removal, liquid or lyophilized forms, preferred tags, and the desired functional sequence range for proteins. Submitting a written inquiry expedites the quoting process.
Connect with us via the live chat in the bottom corner to receive immediate assistance.
Product Overview
| Product Name | Recombinant Human GDF-15 Protein |
| Target Symbol | GDF15 |
| Alternative Names | Growth Differentiation Factor 15, GDF15, MIC-1, Macrophage Inhibitory Cytokine 1, NAG1, PDF, PLAB, Prostate Differentiation Factor, PTGFB, PTGF-beta |
| Accession Number | Q99988 |
| Expression System | CHO cell line. Disulfide-linked homodimer. |
| Molecular Weight | 12.5 kDa (monomer, predicted), 12 kDa and 24 kDa (observed on SDS-PAGE gel stained using Coomassie® Blue under reducing and non-reducing conditions, respectively) |
| Sequence | Ala195-Ile308 |
| Purity | >98% under reducing conditions by SDS-PAGE and quantitative densitometry by Coomassie® Blue staining. |
| Activity | Determined by an alkaline phosphatase activity inhibition assay using mouse MC3T3-E1 cells. The ED50 for this effect is typically <2 ng/mL. |
| Formulation | Lyophilized from sterile Tris and NaCl with Trehalose, pH 7.5 |
| Endotoxin Level | <0.05 EU/1ug of the protein as determined by the LAL method. |
| Shipping | Shipped at ambient temperature. |
| Stability & Storage | 12 months from date of receipt at -20°C to -70°C, lyophilized powder. 3 months at -20°C to -70°C under sterile conditions after reconstitution. Avoid repeated freeze-thaw cycles. |
| Reconstitution | Reconstitute at 100 ug/mL in sterile PBS. |
| Target Function | Growth Differentiation Factor 15 (GDF-15) is part of the Transforming Growth Factor-beta (TGF-β) superfamily. GDF-15 is a dimeric protein consisting of a pro-domain and a mature, biologically active domain. The mature form of GDF-15 contains a conserved cysteine knot structure typical of the TGF-β family. GDF-15 exerts its biological effects by binding to the GFRAL receptor (GDNF family receptor alpha-like) and activates the RET (rearranged during transfection) kinase signaling pathway. This signaling cascade involves phosphorylation events leading to the activation of MAPK, PI3K, and AKT pathways. GDF-15 has been implicated in the regulation of appetite, energy balance, and tissue repair. It can act as a protective response during stress and is involved in processes like apoptosis, tissue remodeling, and the immune response. |
| Tissue Specificity | GDF-15 expression has been reported in liver tissue, adipose tissue, skeletal muscle cells, cardiac tissue, kidney tissue, brain (hypothalamus and hindbrain) tissue, pancreatic cells, lung tissue, macrophages and dendritic cells. |
| Cellular Localization | Secreted protein |
| Involvement In Disease | Dysregulation of GDF-15 has been implicated in tumor progression, metastasis and immune evasion along with cachexia in cancer patients elevated levels of GDF-15 are associated with metabolic abnormalities such as reduced appetite promoting catabolism. Dysregulation of GDF-15 is also associated with atherosclerosis, chronic kidney disease, Alzheimer’s disease, Parkinson’s disease, rheumatoid arthritis, systemic lupus erythematosus (SLE), non-alcoholic fatty liver disease (NAFLD), pre-eclampsia, sarcopenia, and Duchenne muscular dystrophy (DMD). |
